Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 4
1947 8
1948 12
1949 10
1950 56
1951 11
1952 16
1953 21
1954 17
1955 11
1956 30
1957 35
1958 33
1959 23
1960 12
1961 16
1962 32
1963 81
1964 75
1965 33
1966 34
1967 25
1968 26
1969 30
1970 43
1971 46
1972 36
1973 38
1974 26
1975 44
1976 30
1977 35
1978 45
1979 49
1980 34
1981 45
1982 47
1983 46
1984 41
1985 43
1986 48
1987 56
1988 45
1989 72
1990 50
1991 53
1992 63
1993 76
1994 60
1995 59
1996 71
1997 69
1998 64
1999 64
2000 71
2001 76
2002 71
2003 75
2004 107
2005 100
2006 88
2007 104
2008 98
2009 107
2010 132
2011 142
2012 158
2013 142
2014 139
2015 126
2016 153
2017 156
2018 169
2019 162
2020 203
2021 265
2022 242
2023 224
2024 83
2026 1

Text availability

Article attribute

Article type

Publication date

Search Results

5,111 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
Vale ECSD, Garcia LC. Vale ECSD, et al. An Bras Dermatol. 2023 May-Jun;98(3):355-372. doi: 10.1016/j.abd.2022.09.005. Epub 2023 Mar 1. An Bras Dermatol. 2023. PMID: 36868923 Free PMC article. Review.
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusively cutaneous disease or be one of the multiple manifestations of systemic lupus erythematosus. ...This review pr
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusive
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Niebel D, de Vos L, Fetter T, Brägelmann C, Wenzel J. Niebel D, et al. Am J Clin Dermatol. 2023 Jul;24(4):521-540. doi: 10.1007/s40257-023-00774-8. Epub 2023 May 4. Am J Clin Dermatol. 2023. PMID: 37140884 Free PMC article. Review.
Lupus erythematosus comprises a spectrum of autoimmune diseases that may affect various organs (systemic lupus erythematosus [SLE]) or the skin only (cutaneous lupus erythematosus [CLE]). ...A close interdisciplinary exchang
Lupus erythematosus comprises a spectrum of autoimmune diseases that may affect various organs (systemic lupus
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist.
Stull C, Sprow G, Werth VP. Stull C, et al. J Rheumatol. 2023 Jan;50(1):27-35. doi: 10.3899/jrheum.220089. Epub 2022 Sep 15. J Rheumatol. 2023. PMID: 36109075 Free PMC article. Review.
The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations at some point in their disease course. The skin findings in SLE are classified as SLE-specific or SLE-nonspecific based on histopathologic findings. SLE-spec …
The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations at some point in …
Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW, Sontheimer RD. Walling HW, et al. Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19824738 Review.
Cutaneous lupus erythematosus (LE) may present in a variety of clinical forms. Three recognized subtypes of cutaneous LE are acute cutaneous LE (ACLE), subacute cutaneous LE (SCLE), and chronic cutaneous LE (CCLE). ...
Cutaneous lupus erythematosus (LE) may present in a variety of clinical forms. Three recognized subtypes of cutaneou
New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W, Wu H, Zhao M, Lu Q. Zhou W, et al. Expert Rev Clin Immunol. 2020 Aug;16(8):829-837. doi: 10.1080/1744666X.2020.1805316. Epub 2020 Sep 29. Expert Rev Clin Immunol. 2020. PMID: 32746644 Review.
INTRODUCTION: Between 5 and 25% of patients with cutaneous lupus erythematosus (CLE) can progress to systemic lupus erythematosus (SLE) during the course of the disease. There is no clear predictive guideline for the progression of CLE to …
INTRODUCTION: Between 5 and 25% of patients with cutaneous lupus erythematosus (CLE) can progress to systemic
Drug-induced lupus erythematosus: an update on drugs and mechanisms.
He Y, Sawalha AH. He Y, et al. Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522. Curr Opin Rheumatol. 2018. PMID: 29870500 Free PMC article. Review.
RECENT FINDINGS: A large number of proton pump inhibitor (PPI)-induced subacute cutaneous lupus erythematosus cases have been reported, suggesting a shift over time in the spectrum of drugs implicated in DILE. ...Chemotherapeutic drugs were the most common dr …
RECENT FINDINGS: A large number of proton pump inhibitor (PPI)-induced subacute cutaneous lupus erythematosus cases hav …
A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus.
Curtiss P, Walker AM, Chong BF. Curtiss P, et al. Front Immunol. 2022 Mar 11;13:866319. doi: 10.3389/fimmu.2022.866319. eCollection 2022. Front Immunol. 2022. PMID: 35359921 Free PMC article. Review.
Many patients present with cutaneous lupus, where disease is often limited to the skin, but are at risk for developing systemic lupus. The objective of our present study is to perform a systematic review of studies that investigated patient cohorts and …
Many patients present with cutaneous lupus, where disease is often limited to the skin, but are at risk for developing syst
Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysis.
Ma L, Peng L, Zhao J, Bai W, Jiang N, Zhang S, Wu C, Wang L, Xu D, Leng X, Wang Q, Zhang W, Zhao Y, Tian X, Li M, Zeng X. Ma L, et al. Autoimmun Rev. 2023 Dec;22(12):103440. doi: 10.1016/j.autrev.2023.103440. Epub 2023 Sep 9. Autoimmun Rev. 2023. PMID: 37678618 Review.
However, there is still a lack of comprehensive evidence regarding their efficacy and safety in systemic and cutaneous lupus erythematosus. METHODS: We searched for systemic and cutaneous lupus erythematosus patients who wer …
However, there is still a lack of comprehensive evidence regarding their efficacy and safety in systemic and cutaneous lupu
Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus.
Udompanich S, Chanprapaph K, Suchonwanit P. Udompanich S, et al. Am J Clin Dermatol. 2018 Oct;19(5):679-694. doi: 10.1007/s40257-018-0363-8. Am J Clin Dermatol. 2018. PMID: 29948959 Review.
Cutaneous and systemic lupus erythematosus (SLE) commonly involves the hair and scalp. ...This review aims to summarize the clinical pattern, trichoscopic, histopathological, and direct immunofluorescence features of different types of alopecia in c
Cutaneous and systemic lupus erythematosus (SLE) commonly involves the hair and scalp. ...This review aims to su
Cutaneous and systemic connections in lupus.
Maz MP, Michelle Kahlenberg J. Maz MP, et al. Curr Opin Rheumatol. 2020 Nov;32(6):583-589. doi: 10.1097/BOR.0000000000000739. Curr Opin Rheumatol. 2020. PMID: 32826479 Free PMC article. Review.
PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multiple manifestations, with a majority of SLE patients having cutaneous involvement. Despite ongoing research, the relationship between SLE and cuta
PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multiple manifestati …
5,111 results